Article thumbnail

Procalcitonin in liver transplant patients – yet another stone turned

By Jens-Ulrik Jensen and Jens D Lundgren

Abstract

Liver transplantation has been reported to initiate increases in procalcitonin levels, in the absence of bacterial infection. The results of a study investigating the course of procalcitonin levels over several days after liver transplantation in noninfected patients were recently reported in Critical Care. This study shows that procalcitonin levels increase only transiently, immediately after surgery, and thereafter they rapidly decrease. This new information gives us hope that procalcitonin can be used as a marker of bacterial infection in these patients. Further studies of patients undergoing liver transplantation with and without bacterial infection are needed

Topics: Commentary
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2374640
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2000). Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med
  2. (2006). et al.: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med
  3. (2007). Induction of procalcitonin in liver transplant patients treated with anti-thymocyte globulin. Crit Care
  4. (2003). Le Gall JR; European Sepsis Group: Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med
  5. (2006). lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit Care
  6. (2007). McLean AS: Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis
  7. (2001). Procalcitonin increase after anti-CD3 monoclonal antibody therapy does not indicate infectious disease. Transpl Int
  8. (2002). Reference intervals for procalcitonin and C-reactive protein after major abdominal surgery.
  9. (2004). Sgarbi L: Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care
  10. (2006). Tvede M: Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med